Novavax NVAX Balance Sheet

Income Statement

Quarter End	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	2.58B	2.83B	2.62B	2.27B	2.26B	1.54B	1.69B	1.66B
Total Current Assets	2.16B	2.35B	2.14B	1.76B	1.7B	971.03M	1.13B	1.01B
Cash and Equivalents	1.52B	1.57B	1.38B	1.28B	1.34B	624.95M	505.91M	651.1M
Total Non-Current Assets	650.33M	487.47M	486.99M	507.47M	779.68M	571.67M	557.49M	650.39M
Total Liabilities	2.93B	2.77B	3.04B	2.83B	2.89B	2.44B	2.44B	2.34B
Total Current Liabilities	2.39B	2.26B	2.16B	1.67B	2.46B	1.92B	1.6B	1.47B
Total Non-Current Liabilities	861.57M	508.55M	883.7M	1.2B	630.52M	717.27M	1.04B	1.09B
Common Equity	764k	787k	788k	792k	868k	871k	952k	1.2M
Retained Earnings	-3.62B	-3.41B	-3.93B	-4.09B	-4.28B	-4.57B	-4.51B	-4.64B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	394.3M	302.49M	207.98M	172.96M	1.58B	2.58B	2.26B	1.8B
Total Current Assets	287.83M	203.31M	119.28M	97.25M	1.25B	2.16B	1.7B	1.14B
Cash and Equivalents	144.35M	106.31M	70.15M	78.82M	553.4M	1.52B	1.34B	568.51M
Total Non-Current Assets	-5.55M	-101.73M	-167.94M	-186.02M	627.21M	-351.67M	-634.08M	-716.93M
Total Liabilities	399.85M	404.23M	375.91M	358.97M	955.27M	2.93B	2.89B	2.51B
Total Current Liabilities	66.41M	73.68M	45.54M	25.8M	579.67M	2.39B	2.46B	1.64B
Total Non-Current Liabilities	649.78M	648.31M	649.56M	653.79M	737.72M	861.57M	630.52M	1.1B
Total Equity	-5.55M	-101.73M	-167.94M	-186.02M	627.21M	-351.67M	-634.08M	-716.93M
Common Equity	2.72M	3.24M	3.85M	324k	714k	764k	868k	1.41M
Retained Earnings	-930M	-1.11B	-1.3B	-1.43B	-1.87B	-3.62B	-4.28B	-4.82B